A Case Report of Acute Severe Necrotizing Pancreatitis following the Johnson & Johnson Vaccine against the Novel SARS-CoV-2

Author:

Bangolo Ayrton I.1ORCID,Akhter Mahabuba1,Auda Auda1,Akram Rahina1,Nagesh Vignesh K.1,Athem Donnee1,Thomas Reenu1,Tibalan Ligaya1,Trivedi Mansi1,Mushtaq Saima1,Singh Neha1,Bagale Pracheta1,Arana Georgemar V.1,Khan Tayyaba1,Sharma Shelja1,Mynedi Swetha1,Patel Dhara D.1,Saini Mandeep1,Chinthakuntla Madhurya R.1,Ahmed Kareem2,Gad Mary1,Gondhi Srikara Dheer D. R.1,Arana Georgemar1,Gurumoorthy Rohini B.1,Weissman Simcha1ORCID

Affiliation:

1. Department of Internal Medicine, Palisades Medical Center, North Bergen, NJ, USA

2. Department of Internal Medicine, University of Washington, Seattle, Washington, USA

Abstract

Acute pancreatitis is an inflammatory condition, which is a leading gastrointestinal cause of hospitalization in the United States. Several conditions are associated with acute pancreatitis. More recently, there have been a few cases reported of acute pancreatitis following the Pfizer-BioNTech COVID-19 mRNA vaccine. To our knowledge, no cases of acute pancreatitis have been yet reported following the Johnson & Johnson’s Janssen COVID-19 vaccine (J& J vaccine). Herein we report a 34-year-old male with no significant past medical history admitted with acute necrotizing pancreatitis, the day following the receipt of the J&J vaccine. Based on the Naranjo and the modified Naranjo scale, the patient met the requirements for probable drug induced pancreatitis. This case report has the objective to raise awareness of a potentially severe side effect of the J&J vaccine. We hope to use this case to support screening all patients for previous history of acute pancreatitis before administration of the J& J vaccine.

Publisher

Hindawi Limited

Subject

General Medicine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3